Hercules Provides $10 Million Financing to Guava Technologies
News Jan 20, 2006
"Guava Technologies sets the new 'gold standard' for cell-based research and overcomes the limitations of traditional cell analysis methods by providing personal, integrated systems that bring sophisticated cell analysis to the laboratory benchtop and individual scientist," said Kathy Conte, managing director of Hercules.
"Guava's technology offers sensitivity, accuracy and a variety of applications but in a form that is ultra-compact, affordable, easy-to-operate and uses low sample volumes."
"In addition, Guava's technology generates 500 times less waste, and provides rapid, intuitive and easy-to-read results."
"The use of the Guava PCA systems leads to better, faster decision making, resulting in lower research and production costs."
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE
Hidden Signals in RNAs Regulate Protein SynthesisNews
Scientists have long known that RNA encodes instructions to make proteins. In a new study published in Nature, scientists describe how the protein-making machinery identifies alternative initiation sites from which to start protein synthesis.READ MORE
ExPecto Patronum! Magical Machine Learning Tool Summons DNA Dark Matter DataNews
A new machine learning framework, dubbed ExPecto, can predict the effects of mutations in the so-called “dark matter” regions of the human genome. ExPecto pinpoints how mutations can disrupt the way genes turn on and off throughout your body.